Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Anemia 4Uterine Cervical Neoplasms 2Myelodysplastic Syndromes 2Leukemia 2Rectal Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Lymphoma 1Lichen Planus, Oral 1Leukemia, Myelomonocytic, Chronic 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Erectile Dysfunction 1Drug-Related Side Effects and Adverse Reactions 1Bronchiolitis Obliterans Syndrome 1

Interventions

Cyclophosphamide 444Rituximab 401Etoposide 224Vincristine 215Doxorubicin 201Filgrastim 200Prednisone 176Cytarabine 159Radiotherapy 152fludarabine phosphate 147Methotrexate 137Peripheral Blood Stem Cell Transplantation 129Melphalan 127fludarabine 115Busulfan 99Dexamethasone 93Tacrolimus 75Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 71Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 62Cyclosporine 62Bendamustine Hydrochloride 62Lenalidomide 60Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma × Erythropoietin × Clear all
NCT03010579 2017-01-05

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Peking University

Phase 4 Unknown
70 enrolled
Classical hematologyLymphoid

Anemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡